Summarised consolidated statement of profit or lossfor the year ended 30 September 2021
| Notes | 2021 R'm |
Change % |
20201 R'm |
||
| Continuing operations | |||||
| Revenue | 26 885 | 12.7 | 23 851 | ||
| Other income and retirement benefit asset and post-employment medical aid income | 286 | 217 | |||
| Operating expenses | (24 191) | (21 947) | |||
| Operating profit before items below | 2 980 | 40.5 | 2 121 | ||
| Fair value gain/(loss) on financial instruments | 32 | (5) | |||
| Gain on derecognition of lease asset and liability | – | 75 | |||
| Impairment of assets and investments | (14) | (5) | |||
| Profit on remeasuring previously held interest in associate to fair value | 28 | – | |||
| Loss on disposal of property, plant and equipment | (17) | (6) | |||
| Transaction costs relating to acquisitions and disposals | (3) | (8) | |||
| Finance income | 169 | 85 | |||
| Finance cost | (791) | (878) | |||
| Share of associates' and joint ventures' net profit after tax | 25 | 14 | |||
| Profit before tax | 2 409 | 72.9 | 1 393 | ||
| Tax expense | (642) | (556) | |||
| Profit after tax from continuing operations | 1 767 | >100 | 837 | ||
| Discontinued operation | |||||
| Profit/(loss) from discontinued operation | 2 | 87 | (799) | ||
| Profit after tax | 1 854 | >100 | 38 | ||
| Profit after tax attributable to: | |||||
| Ordinary equity holders of the parent | 1 754 | >100 | (93) | ||
| Non-controlling interest | 100 | 131 | |||
| 1 854 | >100 | 38 | |||
| Earnings/(loss) per share (cents) | |||||
| From continuing operations | |||||
| Basic | 114.6 | 136.3 | 48.5 | ||
| Diluted | 114.3 | 136.2 | 48.4 | ||
| From continuing and discontinued operations | |||||
| Basic | 120.6 | >100 | (6.4) | ||
| Diluted | 120.3 | >100 | (6.4) | ||
| 1 | Prior period re-presented. Scanmed S.A. (Scanmed) was disposed of on 26 March 2021 and is included under discontinued operation. Refer note 2. |